ArTS Archivio della ricerca di Trieste

Crocè, Saveria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.512
EU - Europa 7.255
AS - Asia 6.813
SA - Sud America 907
AF - Africa 252
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 17
Totale 27.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.198
SG - Singapore 2.505
IT - Italia 1.677
CN - Cina 1.549
PL - Polonia 1.245
SE - Svezia 835
VN - Vietnam 769
HK - Hong Kong 751
BR - Brasile 685
DE - Germania 633
UA - Ucraina 612
KR - Corea 398
FR - Francia 367
GB - Regno Unito 362
FI - Finlandia 330
RU - Federazione Russa 270
NL - Olanda 202
BG - Bulgaria 197
CA - Canada 193
TR - Turchia 192
IE - Irlanda 174
IN - India 154
AR - Argentina 84
BD - Bangladesh 82
MX - Messico 74
CH - Svizzera 67
MA - Marocco 64
IQ - Iraq 56
SN - Senegal 56
BE - Belgio 49
ES - Italia 47
JP - Giappone 46
PK - Pakistan 41
ZA - Sudafrica 38
ID - Indonesia 36
AT - Austria 34
EC - Ecuador 33
EG - Egitto 31
PH - Filippine 30
SA - Arabia Saudita 27
CO - Colombia 24
CZ - Repubblica Ceca 24
LT - Lituania 23
RO - Romania 22
PY - Paraguay 20
CL - Cile 18
IR - Iran 18
AU - Australia 17
KE - Kenya 17
UZ - Uzbekistan 17
VE - Venezuela 16
DK - Danimarca 15
IL - Israele 15
TH - Thailandia 12
AZ - Azerbaigian 10
EU - Europa 10
HR - Croazia 10
JO - Giordania 10
KZ - Kazakistan 10
TN - Tunisia 10
UY - Uruguay 9
BO - Bolivia 8
DZ - Algeria 8
GR - Grecia 8
LK - Sri Lanka 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
NP - Nepal 7
PE - Perù 7
TW - Taiwan 7
AL - Albania 6
HN - Honduras 6
JM - Giamaica 6
KG - Kirghizistan 6
OM - Oman 6
PT - Portogallo 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
CR - Costa Rica 5
GE - Georgia 5
GT - Guatemala 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
MT - Malta 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
GA - Gabon 3
GY - Guiana 3
HU - Ungheria 3
LV - Lettonia 3
MD - Moldavia 3
MK - Macedonia 3
NO - Norvegia 3
Totale 27.727
Salva come PNG Salva come JPEG
Città #
Singapore 1.418
Ashburn 1.228
Warsaw 1.075
Woodbridge 969
Fairfield 933
Ann Arbor 875
Houston 831
Chandler 828
San Jose 775
Hong Kong 730
Jacksonville 556
Trieste 464
Wilmington 459
Seattle 434
Hefei 382
Seoul 381
Beijing 356
Cambridge 304
Princeton 259
Boardman 241
Ho Chi Minh City 230
Chicago 214
Sofia 193
Los Angeles 173
Hanoi 172
Dublin 166
Dallas 161
Lauterbourg 155
Columbus 154
Izmir 151
London 143
Zgierz 143
Milan 125
Toronto 115
The Dalles 114
Santa Clara 111
Munich 108
Council Bluffs 104
Moscow 104
Helsinki 97
New York 94
Frankfurt am Main 93
Buffalo 83
Dearborn 79
São Paulo 67
San Diego 66
Atlanta 64
Falls Church 58
Rome 58
Dakar 56
Düsseldorf 53
Bern 52
Casablanca 49
Brussels 43
Venezia 42
Orem 41
Dong Ket 40
Redmond 40
Turku 39
Redwood City 38
Des Moines 37
Phoenix 36
Amsterdam 35
Nuremberg 34
Udine 33
Tokyo 32
Montreal 31
Da Nang 30
Denver 30
Guangzhou 30
Krefeld 29
Redondo Beach 29
Haiphong 27
Mexico City 27
Stockholm 27
Vienna 27
Shanghai 26
Verona 26
Mumbai 25
Chennai 24
Boston 23
Rio de Janeiro 23
Baghdad 21
Bremen 21
Dhaka 20
Grafing 20
Jinan 20
Brooklyn 19
Lappeenranta 19
Mestre 19
Norwalk 19
Johannesburg 18
San Francisco 18
Washington 18
Belo Horizonte 17
Poplar 17
Portsmouth 17
Tashkent 17
Venice 17
Kunming 16
Totale 18.560
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 481
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 435
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 407
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 400
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 390
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 383
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 383
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 376
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 349
Gut microbiota characterisation in obese patients before and after bariatric surgery 334
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 299
Anatomy of Basal Ganglia and Thalamus 287
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 273
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 263
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 254
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 254
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 251
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 249
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 244
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 238
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 237
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 231
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 230
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 227
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 223
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 221
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 220
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 217
Semi-automatic Approach to Estimate the Degree of Non-alcoholic Fatty Liver Disease (NAFLD) from Ultrasound Images 214
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 211
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 211
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 209
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 208
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 204
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 203
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 201
Visual impairments and attention in parkinson's disease 199
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 197
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 197
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 196
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 194
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 193
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 193
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 192
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients 192
Aspirin and Infection: A Narrative Review 191
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 189
Stem cells in the development of hepatocellular carcinoma: identification and expression 189
A story of liver and gut microbes: How does the intestinal flora affect liver disease? A review of the literature 189
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19 188
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 187
Diverticular Disease and Rifaximin: An Evidence-Based Review 186
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 185
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 183
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 181
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis 181
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 176
Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature 175
Assessing the feasibility of AI-based Hamaguchi score estimation for NAFLD diagnosis using ultrasound images 174
Deep brain stimulation of the subthalamus: Neuropsychological effects 173
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 172
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 170
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 168
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 168
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 164
Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery 162
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis 161
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 161
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 161
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 161
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 160
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 157
Circulatory mirna as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma 156
Predicting response to non-selective beta-blockers with liver–spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices 152
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 152
Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based framework 151
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents 149
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 147
Spontaneous porto-femoral shunting in long-standing portal hypertension 147
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View 147
Severity of liver disease with different hepatitis C viral clones. 146
null 146
Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience 145
null 143
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 140
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 139
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 139
The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma 136
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 135
Pylephlebitis: A Systematic Review on Etiology, Diagnosis, and Treatment of Infective Portal Vein Thrombosis 133
null 133
The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations 133
Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation 131
null 129
null 129
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 128
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study 128
The importance of transaminases flare in liver elastography: Characterization of the probability of liver fibrosis overestimation by hepatitis C virus-induced cytolysis 126
Advanced Non-linear Modeling and Explainable Artificial Intelligence Techniques for Predicting 30-Day Complications in Bariatric Surgery: A Single-Center Study 125
null 125
Totale 20.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021596 0 0 0 0 0 0 0 0 0 215 120 261
2021/20221.868 60 98 226 204 58 133 103 126 213 167 103 377
2022/20232.513 216 280 167 346 224 454 55 263 321 38 96 53
2023/20241.574 116 90 73 101 171 135 270 314 30 50 130 94
2024/20253.648 64 71 199 364 325 336 318 189 472 490 377 443
2025/20269.374 1.124 555 696 921 946 869 1.504 366 1.121 1.272 0 0
Totale 28.507